RANOLAZINE

Product NDC
50228-423
11-digit product format
502280423
Labeler code
50228
Product ID
50228-423_2a0ac71c-e53c-5ff9-e063-6394a90a4807
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
RANOLAZINE
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
ScieGen Pharmaceuticals, Inc
Application
ANDA211829
Marketing category
ANDA
Marketing start
2019-06-04
Substance
RANOLAZINE
Active strength
500 mg/1
Pharmacologic classes
Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
RANOLAZINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
RANOLAZINE500 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiA6IEZ5M406
Rxcui616749, 728231

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4367aed1-e488-b72c-d0ec-178a4e054129Product name920250624
ddc83a74-720a-4975-8550-c4bd979c9094Product name120221212

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50228-423-05RANOLAZINE500 in 1 PACKAGETABLET, FILM COATED, EXTENDED RE5004
50228-423-30RANOLAZINE30 in 1 PACKAGETABLET, FILM COATED, EXTENDED RE304
50228-423-60RANOLAZINE60 in 1 PACKAGETABLET, FILM COATED, EXTENDED RE604

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50228-423-60EA - Each50228-423165c30f5-922d-4869-b9e5-83f89be1454012019-07-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50228-423RANOLAZINE TABLET, FILM COATED, EXTENDED RELEASE [SCIEGEN PHARMACEUTICALS, INC]4Current NDC, Legacy NDC, 3 package rows20241226_71d50258-75b7-4801-b0f4-c34fe883d57d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
728231ranolazine 1000 MG 12HR Extended Release Oral TabletPSN71d50258-75b7-4801-b0f4-c34fe883d57d4
616749ranolazine 500 MG 12HR Extended Release Oral TabletPSN71d50258-75b7-4801-b0f4-c34fe883d57d4
72823112 HR ranolazine 1000 MG Extended Release Oral TabletSCD71d50258-75b7-4801-b0f4-c34fe883d57d4
61674912 HR ranolazine 500 MG Extended Release Oral TabletSCD71d50258-75b7-4801-b0f4-c34fe883d57d4
728231ranolazine 1000 MG 12 HR Extended Release Oral TabletSY71d50258-75b7-4801-b0f4-c34fe883d57d4
616749ranolazine 500 MG 12 HR Extended Release Oral TabletSY71d50258-75b7-4801-b0f4-c34fe883d57d4

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
50228-423-0550228042305500 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228-423-05) 2019-06-040000-00-00NoNoCurrent
50228-423-305022804233030 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228-423-30) 2019-06-040000-00-00NoNoCurrent
50228-423-605022804236060 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (50228-423-60) 2019-06-040000-00-00NoNoCurrent